Centessa Pharmaceuticals PLC ADR Working Capital to Net Assets Ratio
Centessa Pharmaceuticals PLC ADR working capital to net assets ratio. Centessa Pharmaceuticals PLC ADR (CNTA) has a Working Capital to Net Assets ratio of 64.0% as of March 2026. Working capital of $312.11 Million (current assets of $348.68 Million minus current liabilities of $36.57 Million) is measured against net assets of $487.35 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Centessa Pharmaceuticals PLC ADR (2019–2025)
Working capital to net assets ratio of Centessa Pharmaceuticals PLC ADR from 2019 to 2025. This chart shows how Centessa Pharmaceuticals PLC ADR's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 64.0%, reflecting working capital of $312.11 Million against net assets of $487.35 Million USD. Explore CNTA long-term investments to assets to see how much of total assets are deployed in long-term investments.
Centessa Pharmaceuticals PLC ADR Working Capital to Net Assets Ratio by Year (2019–2025)
Centessa Pharmaceuticals PLC ADR working capital to net assets ratio by year from 2019 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Centessa Pharmaceuticals PLC ADR from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Centessa Pharmaceuticals PLC ADR total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 61.7% | $324.94 Million | $526.86 Million | $367.88 Million | $42.94 Million | ▼ -57.5 pp |
| 2024 | 119.1% | $478.41 Million | $401.55 Million | $536.41 Million | $58.00 Million | ▲ +2.4 pp |
| 2023 | 116.7% | $275.71 Million | $236.24 Million | $315.09 Million | $39.38 Million | ▼ -2.1 pp |
| 2022 | 118.8% | $399.41 Million | $336.17 Million | $437.75 Million | $38.34 Million | ▼ -4.1 pp |
| 2021 | 122.9% | $604.14 Million | $491.55 Million | $628.77 Million | $24.64 Million | ▲ +40.7 pp |
| 2020 | 82.2% | $2.55 Million | $3.10 Million | $11.16 Million | $8.62 Million | ▼ -44.4 pp |
| 2019 | 126.6% | $17.30 Million | $13.66 Million | $19.23 Million | $1.93 Million | — |